Copper(II) binding to the amyloid-β peptide has been proposed to be a key event in the cascade leading to Alzheimer’s disease. As a direct consequence, the strength of the Cu(II) to Aβ interaction, that is, the Cu(II) affinity of Aβ, is a very important parameter to determine. Because Aβ peptide contain one Tyr fluorophore in its sequence and because Cu(II) does quench Tyr fluorescence, fluorescence measurements appear to be a straightforward way to obtain this parameter. However, this proved to be wrong, mainly because of data misinterpretation in some previous studies that leads to a conflicting situation. In the present paper, we have investigated in details a large set of fluorescence data that were analyzed with a new method taking...
In this work we analyze at a structural level the mechanism by which Cu(II) and Zn(II) ions compet...
Alzheimer's disease (AD), an irreversible, progressive and devastating neurodegenerative disease, is...
Alzheimer’s disease (AD) patients show abnormally high concentrations of Cu<sup>2+</sup> in the amyl...
International audienceBeing able to easily determine the Cu(II) affinity for biomolecules of moderat...
International audienceIn the present micro-review, we describe the Cu(II) binding to several forms o...
Interactions of amyloid beta (Abeta) peptides with Cu(II) are believed to play a crucial role in the...
Cu and Zn have been shown to accumulate in the brains of Alzheimer's disease patients. We have previ...
Alzheimer’s disease (AD) is the main cause of age-related dementia and currently affects approximate...
International audienceAlthough the interaction between the β-amyloid peptide and copper (II) appears...
Copper coexists with amyloid-β (Aβ) peptides at a high concentration in the senile plaques of Alzhei...
Alzheimer’s Disease (AD) is a progressive, neurodegenerative disease that affects 35 million people ...
A non‐invasive intrinsic fluorescence sensing of the early stages of Alzheimer’s beta amyloid peptid...
N-Truncated Aβ4–42 displays a high binding affinity with CuII. A mechanistic scheme of the interacti...
Considerable effort is being directed at unraveling the molecular mechanisms of Alzheimer's disease ...
Alzheimer's disease (AD) an irreversible progressive and devastating neurodegenerative disease is th...
In this work we analyze at a structural level the mechanism by which Cu(II) and Zn(II) ions compet...
Alzheimer's disease (AD), an irreversible, progressive and devastating neurodegenerative disease, is...
Alzheimer’s disease (AD) patients show abnormally high concentrations of Cu<sup>2+</sup> in the amyl...
International audienceBeing able to easily determine the Cu(II) affinity for biomolecules of moderat...
International audienceIn the present micro-review, we describe the Cu(II) binding to several forms o...
Interactions of amyloid beta (Abeta) peptides with Cu(II) are believed to play a crucial role in the...
Cu and Zn have been shown to accumulate in the brains of Alzheimer's disease patients. We have previ...
Alzheimer’s disease (AD) is the main cause of age-related dementia and currently affects approximate...
International audienceAlthough the interaction between the β-amyloid peptide and copper (II) appears...
Copper coexists with amyloid-β (Aβ) peptides at a high concentration in the senile plaques of Alzhei...
Alzheimer’s Disease (AD) is a progressive, neurodegenerative disease that affects 35 million people ...
A non‐invasive intrinsic fluorescence sensing of the early stages of Alzheimer’s beta amyloid peptid...
N-Truncated Aβ4–42 displays a high binding affinity with CuII. A mechanistic scheme of the interacti...
Considerable effort is being directed at unraveling the molecular mechanisms of Alzheimer's disease ...
Alzheimer's disease (AD) an irreversible progressive and devastating neurodegenerative disease is th...
In this work we analyze at a structural level the mechanism by which Cu(II) and Zn(II) ions compet...
Alzheimer's disease (AD), an irreversible, progressive and devastating neurodegenerative disease, is...
Alzheimer’s disease (AD) patients show abnormally high concentrations of Cu<sup>2+</sup> in the amyl...